---
authors:
- Ebell, Mark H
category: Clinical Review
clinical_significance: High
external_resources:
- title: PubMed Entry
  type: reference
  url: https://pubmed.ncbi.nlm.nih.gov/40531163/
file_path: 2025/06/zoledronate-given-twice-5-years-apart-to-women-with-normal-b.md
issue: '6'
last_updated: '2025-07-30'
original_format: PubMed
pages: '560'
patient_population: Adults
peer_reviewed: true
pmid: '40531163'
processed_date: '2025-07-30'
publication_date: '2025-06-01'
pubmed_enriched: true
pubmed_enriched_date: '2025-08-10'
reading_time_minutes: 5
source: American family physician
specialty:
- Family Medicine
status: processed
tags:
- clinical-review
- family-practice
- clinical-medicine
- pubmed-enhanced
title: Zoledronate Given Twice 5 Years Apart to Women With Normal Bone Density or
  Osteopenia Reduces Fracture Risk.
topics:
- Family Medicine
volume: '111'
publication_types: &id001
- Journal Article
pubmed_content_enriched: true
pubmed_full_data:
  pmid: '40531163'
  title: Zoledronate Given Twice 5 Years Apart to Women With Normal Bone Density or
    Osteopenia Reduces Fracture Risk.
  authors:
  - last_name: Ebell
    fore_name: Mark H
    initials: MH
  journal_info:
    title: American family physician
    iso_abbreviation: Am Fam Physician
    volume: '111'
    issue: '6'
  publication_info:
    year: '2025'
    month: '06'
    full_date: '2025-06-01'
  article_ids: {}
  publication_types: *id001
related_articles:
- pmid: '40531163'
  title: Zoledronate Given Twice 5 Years Apart to Women With Normal Bone Density or
    Osteopenia Reduces Fracture Risk.
  authors:
  - name: Ebell MH
    authtype: Author
    clusterid: ''
  source: Am Fam Physician
  pubdate: 2025 Jun
- pmid: '30575489'
  title: Fracture Prevention with Zoledronate in Older Women with Osteopenia.
  authors:
  - name: Reid IR
    authtype: Author
    clusterid: ''
  - name: Horne AM
    authtype: Author
    clusterid: ''
  - name: Mihov B
    authtype: Author
    clusterid: ''
  - name: Stewart A
    authtype: Author
    clusterid: ''
  - name: Garratt E
    authtype: Author
    clusterid: ''
  - name: Wong S
    authtype: Author
    clusterid: ''
  - name: Wiessing KR
    authtype: Author
    clusterid: ''
  - name: Bolland MJ
    authtype: Author
    clusterid: ''
  - name: Bastin S
    authtype: Author
    clusterid: ''
  - name: Gamble GD
    authtype: Author
    clusterid: ''
  source: N Engl J Med
  pubdate: 2018 Dec 20
- pmid: '28893875'
  title: 'Duration of antiresorptive activity of zoledronate in postmenopausal women
    with osteopenia: a randomized, controlled multidose trial.'
  authors:
  - name: Grey A
    authtype: Author
    clusterid: ''
  - name: Bolland MJ
    authtype: Author
    clusterid: ''
  - name: Horne A
    authtype: Author
    clusterid: ''
  - name: Mihov B
    authtype: Author
    clusterid: ''
  - name: Gamble G
    authtype: Author
    clusterid: ''
  - name: Reid IR
    authtype: Author
    clusterid: ''
  source: CMAJ
  pubdate: 2017 Sep 11
- pmid: '30887607'
  title: 'Anti-fracture efficacy of zoledronate in subgroups of osteopenic postmenopausal
    women: secondary analysis of a randomized controlled trial.'
  authors:
  - name: Reid IR
    authtype: Author
    clusterid: ''
  - name: Horne AM
    authtype: Author
    clusterid: ''
  - name: Mihov B
    authtype: Author
    clusterid: ''
  - name: Stewart A
    authtype: Author
    clusterid: ''
  - name: Garratt E
    authtype: Author
    clusterid: ''
  - name: Wiessing KR
    authtype: Author
    clusterid: ''
  - name: Bolland MJ
    authtype: Author
    clusterid: ''
  - name: Bastin S
    authtype: Author
    clusterid: ''
  - name: Gamble GD
    authtype: Author
    clusterid: ''
  source: J Intern Med
  pubdate: 2019 Aug
- pmid: '33039577'
  title: Cost-effectiveness of treatment of women aged 70Â years and older with both
    osteopenia and microstructural deterioration.
  authors:
  - name: Liew D
    authtype: Author
    clusterid: ''
  - name: Chapurlat RD
    authtype: Author
    clusterid: ''
  - name: Sornay-Rendu E
    authtype: Author
    clusterid: ''
  - name: Lespessailles E
    authtype: Author
    clusterid: ''
  - name: Peng Y
    authtype: Author
    clusterid: ''
  - name: Seeman E
    authtype: Author
    clusterid: ''
  source: Bone
  pubdate: 2021 Jan
---

# Zoledronate Given Twice 5 Years Apart to Women With Normal Bone Density or Osteopenia Reduces Fracture Risk.

**Authors:** Ebell, Mark H

**Published in:** American family physician | Vol. 111, No. 6 | 2025-06-01

**Links:** [PubMed](https://pubmed.ncbi.nlm.nih.gov/40531163/)

## Clinical Information

**Population:** Adults | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Family Medicine

## Article Content

*Full article content to be extracted and formatted from source material.*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/40531163/) (reference)

---

*Processed: 2025-07-30* | *PubMed Enhanced: 2025-07-30*
